This Global Tuberculosis Diagnostics market report studies the industry based on one or more segments covering key players, types, applications, products, technology, end-users, and regions for historical data as well as provides forecasts for next few years.
Selbyville, DE -- (SBWIRE) -- 02/05/2019 -- Market Study Report adds Global Tuberculosis Diagnostics market report that gives meticulous investigation of current scenario of the market size, share, demand, growth, trends, companies active in the industry and forecasts for the coming years.
Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those infected. The classic symptoms of active TB are a chronic cough with blood-containing sputum, fever, night sweats, and weight loss. The historical term "consumption" came about due to the weight loss. Infection of other organs can cause a wide range of symptoms.
Request a sample of this premium report on Tuberculosis Diagnostics market at: https://www.marketstudyreport.com/request-a-sample/1476838/?utm_source=Releasewire.com-AN
The classification of Tuberculosis diagnostics includes culture-based diagnostics, sputum smear microscopy diagnostics, rapid molecular diagnostics and so on. And the proportion of Culture-based Diagnostic in 2017 is about 34.84%, and the proportion is in decreasing trend from 2013 to 2017.
Tuberculosis Diagnostics is widely used in hospital, diagnostic laboratories and other field. The most proportion of Tuberculosis Diagnostics is hospital, and the revenue in 2017 is 542 M USD.
Europe is the largest consumption place, with a Revenue market share nearly 42.03% in 2017. Following Europe, Africa is the second largest consumption place with the Revenue market share of 35.76%.
The global Tuberculosis Diagnostics market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
Tuberculosis Diagnostics Market Report – Quick Rundown:
Vendors discussed with company profiles, details on their offerings, contact information and more include: Abbott Laboratories, Becton, Dickinson and Company, Alere, Inc., BioMerieux SA, F.Hoffmann-La Roche AG, Thermo Fisher Scientific, Siemens, Cepheid, Akonni Biosystems, Hain Lifesciences GmBH, NanoEnTe
Global Tuberculosis Diagnostics Market Type Segments Covered:
- Smear Microscopy
- LF-LAM For PLHIV
- Molecular Testing
- Drug Susceptibility Testing
- Mantoux Tuberculin Testing
World Tuberculosis Diagnostics Market 2018 – 2023 Analysis of Segments by Applications include:
- Diagnostic laboratories
Request a discount on standard prices of this premium report at: https://www.marketstudyreport.com/check-for-discount/1476838/
To study and analyze the global Tuberculosis Diagnostics consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2024.
To understand the structure of Tuberculosis Diagnostics market by identifying its various subsegments.
Focuses on the key global Tuberculosis Diagnostics manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Tuberculosis Diagnostics with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Tuberculosis Diagnostics submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
More Details on this Report At: https://www.marketstudyreport.com/reports/global-tuberculosis-diagnostics-market-professional-survey-report-2019
Table of Contents
2018-2023 Global Tuberculosis Diagnostics Consumption Market Report
1 Scope of the Report
2 Executive Summary
3 Global Tuberculosis Diagnostics by Players
4 Tuberculosis Diagnostics by Regions
8 Middle East & Africa
9 Market Drivers, Challenges and Trends
10 Marketing, Distributors and Customer
11 Global Tuberculosis Diagnostics Market Forecast
12 Key Players Analysis
13 Research Findings and Conclusion
Global Tuberculosis Diagnostics Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB).
Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those infected. The classic symptoms of active TB are a chronic cough with blood-containing sputum, fever, night sweats, and weight loss. The historical term "consumption" came about due to the weight loss. Infection of other organs can cause a wide range of symptoms.
About Market Study Report
Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.
Market Study Report LLC
4 North Main Street,
Selbyville, Delaware 19975
US Toll Free: 1-866-764-2150